VEEV241220C250000
- 0.01
- -0.04-80.00%
Veeva Systems Newsroom
Stephens Initiates Veeva Systems(VEEV.US) With Buy Rating, Announces Target Price $280
Veeva Systems Analyst Ratings
Veeva Systems Is Maintained at Underweight by Morgan Stanley
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Raises Target Price to $195
Morgan Stanley Sticks to Its Sell Rating for Veeva Systems (VEEV)
Veeva Systems Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Conmed (CNMD) and Veeva Systems (VEEV)
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $183
Truist Financial Keeps Their Hold Rating on Veeva Systems (VEEV)
Truist Financial Maintains Veeva Systems(VEEV.US) With Hold Rating, Maintains Target Price $261
Veeva Systems Analyst Ratings
Mizuho Securities Maintains Veeva Systems(VEEV.US) With Buy Rating, Announces Target Price $280
Citi Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $307
A Quick Look at Today's Ratings for Veeva Systems(VEEV.US), With a Forecast Between $183 to $300
Veeva Systems Is Maintained at Neutral by B of A Securities
KeyBanc Raises Veeva Systems Price Target to $285 From $240, Maintains Overweight Rating
Stifel Maintains Buy on Veeva Systems, Raises Price Target to $272
A Quick Look at Today's Ratings for Veeva Systems(VEEV.US), With a Forecast Between $183 to $290
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Monte Rosa Therapeutics (GLUE) and CAMP4 Therapeutics Corporation (CAMP)
Veeva Systems (VEEV) Gets a Buy From RBC Capital